Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
Clinical trial NCT06040086 · COMPLETED
Trial details
- NCT number
- NCT06040086
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-22
- Primary completion
- 2026-03-06
- Enrollment
- 1454
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.